This month's main topic: Improving Your Error Investigation Skills: Common Pitfalls when Conducting a Root Cause Analysis

ISMP Medication Safety Alert!®
Community/Ambulatory
A valuable resource to reduce medication error risk in outpatient settings
The ISMP Medication Safety Alert!®Community/Ambulatory Care is a 4-5 page digital newsletter, published monthly for healthcare practitioners in ambulatory settings, including community pharmacies, outpatient clinics, physician offices, and state institutions.
Who reads this newsletter?
- Community/ambulatory care pharmacists
- Pharmacy managers and executives
- Pharmacy technicians and other pharmacy staff
- Physicians and nurses in ambulatory practice
- Anyone concerned with medication safety
Subscription Information
- Twelve (12) issues per year
- One-year subscription rate: $62
- Distributed via email on a monthly basis
- Special pricing for group purchases; contact ISMP
Browse Issues
Community/Ambulatory
Volume 17, Issue 2
This month's main topic: A Problem that Still Needs "Ironed" Out: Label Improvements Needed for Iron Products
Community/Ambulatory
VOLUME 17, ISSUE 1
This month's main topic: QuarterWatch™ (2 years of data ending June 2017): Safety Signals for Pharmaceutical Contraceptives
Community/Ambulatory
Volume 16, Issue 12
This month's main topic: Celebrating the Heart & Soul of Medication Safety: ISMP Cheers Awards 20th Anniversary
Community/Ambulatory
VOLUME 16, ISSUE 11
This month's main topic: QuarterWatch™ (2017 Quarter 1 Data): Safety Signals for Two Novel Drugs, Nuplazid and Entresto
Community/Ambulatory
VOLUME 16, ISSUE 10
This month's main topic: Alert! Severe Hyperglycemia in Patients Incorrectly Using Insulin Pens at Home
Community/Ambulatory
VOLUME 16, ISSUE 9
The month's main topic: Telling Stories is an ISMP Hallmark: Here’s Why You Should Tell Stories, Too
Community/Ambulatory
VOLUME 16, ISSUE 8
This month's main topic: Multifactorial Causes of Tacrolimus Errors
Community/Ambulatory
VOLUME 16, ISSUE 7
This month's main topic: QuarterWatch™ 2016 Annual Report: Signals for Oral Anticoagulants and Drugs with Withdrawal Effects